Evaluation of liver function tests in scleroderma patients

Rheumatology International

Volumn 32, Issue 8, 2012, Pages 2371-2375

  Salem, Gehan Ibrahim Abdelrazek ^a,b   Abdulrahman, Awni Ali ^b  

^a Assiut University Faculty of Medicine   (Egypt)

^b KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

Liver disease; Scleroderma; Systemic sclerosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AUTOANTIBODY; CAPTOPRIL; COLCHICINE; CYCLOPHOSPHAMIDE; DILTIAZEM; GAMMA GLUTAMYLTRANSFERASE; MITOCHONDRION ANTIBODY; NIFEDIPINE; PENICILLAMINE; PREDNISONE; SMOOTH MUSCLE ANTIBODY;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; INCIDENCE; LIVER DISEASE; LIVER FUNCTION TEST; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; SCLERODERMA; SYSTEMIC SCLEROSIS;

ADULT; AGED; ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CLINICAL ENZYME TESTS; EGYPT; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; LIVER; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; MIDDLE AGED; MITOCHONDRIA; MUSCLE, SMOOTH; PREDICTIVE VALUE OF TESTS; SCLERODERMA, LOCALIZED; SCLERODERMA, SYSTEMIC;

EID: 84866252517     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-1963-2     Document Type: Article

References (26)

1. Haustein UF (2002) Systemic sclerosis-Scleroderma. Dermatol Online J 8(1):3
2. Le Roy EC, Black C, Fleischmajer R et al (1988) Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 15:202-205
3. Sackner MA (1962) The visceral manifestations of scleroderma. Arthritis Rheum 5:184-196
4. Miller F, Lane B, Soterakis J, D'Angelo WA (1979) Primary biliary cirrhosis and scleroderma. The possibility of a common pathogenetic mechanism. Arch Pathol Lab Med 103:505-509
5. Preliminary criteria for the classification of systemic sclerosis (scleroderma) (1980) Subcommittee for scleroderma criteria of the american rheumatism association diagnostic and therapeutic criteria committee. Arthritis Rheum 23(5):581-590
6. Maricq HR, Harper FE, Khan MM (1983) Microvascular abnormalities as possible predictors of disease subsets in Raynaud's phenomenon and early connective tissue disease. Clin Exp Rheumatol 1:195-205
7. Silman AJ (1991) Epidemiology of scleroderma. Ann Rheum Dis 50:846-853
8. Steen VD, Medsger TA Jr (2000) Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 11:2437-2444
9. Bartholomew LG, Cain JC, Winkelmann RK, Baggenstoss AH (1964) Chronic disease of the liver associated with systemic scleroderma. Am J Dig Dis 9:43-55
10. Clarke AK, Galbraith RM, Hamilton EBD, Williams R (1978) Rheumatic disorders in primary biliary cirrhosis. Ann Rheum Dis 37:42-47
11. Makinen D, Fritzler JM, Davis P, Sherlock S (1983) Anticentromere antibodies in primary biliary cirrhosis. Arthritis Rheum 26:914-917
12. D'Angelo WA, Fries JF, Masi AT, Shulman LE (1969) Pathologic observations in systemic sclerosis (scleroderma). A study of fiftyeight autopsy cases and fifty-eight matched controls. Am J Med 46(3):428-440
13. Murray Lyon IM, Thompson RP, Ansell ID, Williams R (1970) Scleroderma and primary biliary cirrhosis. Br Med J 1:258-259
14. Goetz RH, Berne MB (1945) The pathology of progressive systemic sclerosis (generalized scleroderma): with special reference to changes in the viscera. Clin Proc 4:337-392
15. Reynolds TB, Denison EK, Frankl HD, Lieberman FL, Peters RL (1970) New syndrome. Combination of primary biliary cirrhosis, scleroderma and hereditary hemorrhagic teliangectasia. Gastroenterology 58:290
16. Gonzalez-Lopez MA, Drake M, Gonzalez-Vela MC, Armesto S, Llaca HF, Val-Bernal JF (2006) Generalized morphea and primary biliary cirrhosis coexisting in a male patient. J Dermatol 33(10):709-713
17. Khalifa M, Ben Jazia E, Hachfi W, Sriha B, Bahri F, Letaief A (2006) Autoimmune hepatitis and morphea: a rare association. Gastroenterol Clin Biol 30(6-7):917-918
18. Marie I, Levesque H, Tranvouez JL et al (2001) Autoimmune hepatitis and systemic sclerosis: a new overlap syndrome? Rheumatology (Oxford) 40(1):102-106
19. Kaburaki J, Kuramochi S, Fujii T et al (1996) Nodular regenerative hyperplasia of the liver in a patient with systemic sclerosis. Clin Rheumatol 15(6):613-616
20. Fraile G, Rodriguez-Garcia JL, Moreno A (1991) Primary sclerosing cholangitis associated with systemic sclerosis. Postgrad Med J 67(784):189-192
21. Le Roy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28:1573-1576
22. Okano Y (1996) Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 22:709-735
23. Fanning GC, Welsh KI, Bunn C, Du Bois R, Black CM (1998) HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients. Br J Rheumatol 37:201-207
24. Harvey GR, McHugh NJ (1999) Serologic abnormalities in systemic sclerosis. Curr Opin Rheumatol 11:495-502
25. Moroi Y, Peebles C, Fritzler MJ, Steigerwald J, Tan EM (1980) Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci USA 77:1627-1631
26. Abraham S, Begum S, Isenberg D et al (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63(2):123-129